GNRH1 and cancer: One of the methods that is used for the engineering of targeted cancer therapy is based on the discovery that tumors produce higher levels of receptors for peptide hormones such as somatostatin, bombesin, and LHRH (now identified in genome and microarray databases as GNRH1) than most normal cells11,12.